Clinical Trial: Integration of Venous Excess Ultrasound Score (VEXUS) Into the ESC/ERS 2022 Simplified Risk Model in Pulmonary Arterial Hypertension: A Prospective Observational Study

U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07266012) titled 'Integration of Venous Excess Ultrasound Score (VEXUS) Into the ESC/ERS 2022 Simplified Risk Model in Pulmonary Arterial Hypertension: A Prospective Observational Study' on Nov. 23.

Brief Summary: This prospective observational study aims to evaluate the relationship between the Venous Excess Ultrasound Score (VEXUS) and the ESC/ERS 2022 simplified four-strata risk assessment model in adult patients with World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH). The study investigates whether VEXUS can enhance risk stratification and predict haemodynamic congestion by correlating VEXUS with functional, biochemical,...